Pregabalin: here's the fair price
This is what US pharmacies pay, on average, for pregabalin. Use it to spot a fair cash price, and feel good about asking for one.
Pregabalin 25 Mg Capsule
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Pregabalin 25 Mg Capsule. Pharmacies pay about $1.34 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| PREGABALIN 25 MG CAPSULEGeneric | $0.04 per tablet or capsule | $1.34 | 10/21/2026 |
| PREGABALIN 50 MG CAPSULEGeneric | $0.05 per tablet or capsule | $1.43 | 10/21/2026 |
| PREGABALIN 75 MG CAPSULEGeneric | $0.06 per tablet or capsule | $1.67 | 10/21/2026 |
| PREGABALIN 150 MG CAPSULEGeneric | $0.06 per tablet or capsule | $1.76 | 10/21/2026 |
| PREGABALIN 100 MG CAPSULEGeneric | $0.06 per tablet or capsule | $1.81 | 10/21/2026 |
| PREGABALIN 200 MG CAPSULEGeneric | $0.06 per tablet or capsule | $1.87 | 10/21/2026 |
| PREGABALIN 225 MG CAPSULEGeneric | $0.07 per tablet or capsule | $2.05 | 10/21/2026 |
| PREGABALIN 300 MG CAPSULEGeneric | $0.07 per tablet or capsule | $2.07 | 10/21/2026 |
| PREGABALIN 20 MG/ML SOLUTIONGeneric | $0.15 per mL | n/a | 10/21/2026 |
| PREGABALIN ER 165 MG TABLETGeneric | $1.63 per tablet or capsule | $48.90 | 10/21/2026 |
| PREGABALIN ER 330 MG TABLETGeneric | $2.23 per tablet or capsule | $67.04 | 10/21/2026 |
| PREGABALIN ER 82.5 MG TABLETGeneric | $2.35 per tablet or capsule | $70.61 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1 ) Postherpetic neuralgia (PHN) (1) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1) Fibromyalgia ( 1) Neuropathic pain associated with spinal cord injury (1 )
Common side effects (FDA label)
6 ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Angioedema [see Warnings and Precautions (5.1) ] Hypersensitivity [see Warnings and Precautions (5.2) ] Suicidal Behavior and Ideation [see Warnings and Precautions (5.3) ] Respiratory Depression [see Warnings and Precautions (5.4) ] Dizziness and Somnolence [see Warnings and Precautions (5.5) ] Increased Risk of Adverse Reactions with Abrupt or Rapid Discontinuation [see Warnings and Precautions (5.6) ] Peripheral Edema [see Warnings and Precautions (5.7) ] Weight Gain [see Warnings and...
Drug interactions (from the label)
7 DRUG INTERACTIONS Since pregabalin is predominantly excreted unchanged in the urine, undergoes negligible metabolism in humans (less than 2% of a dose recovered in urine as metabolites), and does not bind to plasma proteins, its pharmacokinetics are unlikely to be affected by other agents through metabolic interactions or protein binding displacement. In vitro and in vivo studies showed that pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions. Specifically, there are no pharmacokinetic interactions between pregabalin and the following antiepileptic drugs: carbamazepine, valproic acid, lamotrigine, phenytoin, phenobarbital, and topiramate. Important...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS Angioedema (e.g., swelling of the throat, head and neck) can occur, and may be associated with life-threatening respiratory compromise requiring emergency treatment. Discontinue pregabalin immediately in these cases. ( 5.1 ) Hypersensitivity reactions (e.g., hives, dyspnea, and wheezing) can occur. Discontinue pregabalin immediately in these patients. ( 5.2 ) Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. ( 5.3 ) Respiratory depression: May occur with pregabalin, when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Monitor patients and adjust dosage as appropriate. (5.4 )...
Source: FDA drug label via openFDA, label effective 2025-09-23. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.